Huaizhou You

609 total citations
24 papers, 444 citations indexed

About

Huaizhou You is a scholar working on Nephrology, Surgery and Physiology. According to data from OpenAlex, Huaizhou You has authored 24 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 4 papers in Surgery and 4 papers in Physiology. Recurrent topics in Huaizhou You's work include Parathyroid Disorders and Treatments (5 papers), Acute Kidney Injury Research (4 papers) and Muscle and Compartmental Disorders (3 papers). Huaizhou You is often cited by papers focused on Parathyroid Disorders and Treatments (5 papers), Acute Kidney Injury Research (4 papers) and Muscle and Compartmental Disorders (3 papers). Huaizhou You collaborates with scholars based in China, United States and Italy. Huaizhou You's co-authors include Yong Gu, Feng Ding, Shanyan Lin, Ying Zhou, Chuan‐Ming Hao, Raymond C. Harris, Jianchun Chen, Xu You, Qionghong Xie and Yan Li and has published in prestigious journals such as PLoS ONE, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Huaizhou You

20 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huaizhou You China 11 193 79 77 66 56 24 444
Margien G. S. Boels Netherlands 8 233 1.2× 53 0.7× 73 0.9× 103 1.6× 64 1.1× 10 636
Julio P. Juncos United States 11 170 0.9× 66 0.8× 213 2.8× 104 1.6× 103 1.8× 11 512
Qunzi Zhang China 12 196 1.0× 15 0.2× 135 1.8× 75 1.1× 48 0.9× 20 488
Vincenzo Scivittaro United States 7 191 1.0× 22 0.3× 72 0.9× 70 1.1× 102 1.8× 12 453
F. Uccello Italy 11 245 1.3× 33 0.4× 64 0.8× 71 1.1× 70 1.3× 20 428
Jürgen Muser Switzerland 8 93 0.5× 11 0.1× 69 0.9× 75 1.1× 39 0.7× 11 402
Yoshihisa Ogawa Japan 11 252 1.3× 11 0.1× 145 1.9× 58 0.9× 55 1.0× 15 513
Steve Lund United States 8 156 0.8× 19 0.2× 118 1.5× 60 0.9× 49 0.9× 8 392
K. W. Rumpf Germany 15 123 0.6× 37 0.5× 95 1.2× 110 1.7× 79 1.4× 38 534
Zager Ra United States 12 161 0.8× 19 0.2× 115 1.5× 91 1.4× 71 1.3× 15 382

Countries citing papers authored by Huaizhou You

Since Specialization
Citations

This map shows the geographic impact of Huaizhou You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaizhou You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaizhou You more than expected).

Fields of papers citing papers by Huaizhou You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaizhou You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaizhou You. The network helps show where Huaizhou You may publish in the future.

Co-authorship network of co-authors of Huaizhou You

This figure shows the co-authorship network connecting the top 25 collaborators of Huaizhou You. A scholar is included among the top collaborators of Huaizhou You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaizhou You. Huaizhou You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
You, Huaizhou, Ye Yao, Yan Zheng, et al.. (2025). eGFR–ACR Risk Stratification of Rapid Kidney Function Decline Across Aging Phenotypes in Older Chinese Adults. Clinical Interventions in Aging. Volume 20. 2105–2118.
3.
Chen, Xujiao, Mengjing Wang, Jing Qian, et al.. (2023). Plasma Aβ42:Aβ40 ratio as a biomarker for cognitive impairment in haemodialysis patients: a multicentre study. Clinical Kidney Journal. 16(11). 2129–2140. 5 indexed citations
4.
You, Huaizhou, Mengjing Wang, Jing Qian, et al.. (2023). Single-cell RNA sequencing reveals transdifferentiation of parathyroid chief cells into oxyphil cells in patients with uremic secondary hyperparathyroidism. Kidney International. 105(3). 562–581. 5 indexed citations
5.
Ni, Li, Huaizhou You, Mengjing Wang, Jing Qian, & Jing Chen. (2022). Bromodeoxyuridine Methodology for Labeling Renal Stem Cells During Kidney Development of Mice. Stem Cells and Development. 31(7-8). 195–206.
6.
Qian, Jing, Mengjing Wang, Huaizhou You, et al.. (2022). Early Renal-Replacement Therapy May Reduce the All-Cause Mortality of Severe COVID-19: An Observational Cohort Study. Blood Purification. 51(12). 1006–1014. 2 indexed citations
7.
You, Huaizhou, Mengjing Wang, Li Ni, et al.. (2022). Integrated transcriptomic and proteomic analyses for the characterization of parathyroid oxyphil cells in uremic patients. Amino Acids. 54(5). 749–763. 4 indexed citations
8.
Gu, Jie, et al.. (2022). High sodium reduced the expression of PTH1R and Klotho by inhibiting 1,25(OH)2D3 synthesis in cultured proximal tubule epithelial cells. Annals of Translational Medicine. 10(9). 506–506. 2 indexed citations
9.
You, Huaizhou, et al.. (2021). High‐phosphorus diet controlled for sodium elevates blood pressure in healthy adults via volume expansion. Journal of Clinical Hypertension. 23(4). 849–859. 7 indexed citations
10.
Zhu, Xiaoye, et al.. (2020). Complete remission of nephrotic syndrome in a young woman with anti-LRP2 nephropathy after immunosuppressive therapy. BMC Nephrology. 21(1). 364–364. 3 indexed citations
11.
Lai, Lingyun, Jing Qian, Qionghong Xie, et al.. (2013). Is the Serum Vitamin D Level at the Time of Hospital-Acquired Acute Kidney Injury Diagnosis Associated with Prognosis?. PLoS ONE. 8(5). e64964–e64964. 29 indexed citations
12.
Zheng, Yin, Qiuyu Zhu, Junfeng Liu, et al.. (2013). Citrate Pharmacokinetics in Critically Ill Patients with Acute Kidney Injury. PLoS ONE. 8(6). e65992–e65992. 28 indexed citations
13.
Qian, Jing, Huaizhou You, Qiuyu Zhu, et al.. (2013). Nitrotyrosine Level Was Associated with Mortality in Patients with Acute Kidney Injury. PLoS ONE. 8(11). e79962–e79962. 21 indexed citations
14.
Xie, Qionghong, Ying Zhou, Dingwei Kuang, et al.. (2011). The ratio of CRP to prealbumin levels predict mortality in patients with hospital-acquired acute kidney injury. BMC Nephrology. 12(1). 30–30. 61 indexed citations
15.
Lv, Fang, Huaizhou You, Bobin Chen, et al.. (2010). Mannitol is an independent risk factor of acute kidney injury after cerebral trauma: a case–control study. Renal Failure. 32(6). 673–679. 47 indexed citations
16.
You, Huaizhou, Ye Lu, Dingkun Gui, et al.. (2010). Aqueous extract of Astragali Radix ameliorates proteinuria in adriamycin nephropathy rats through inhibition of oxidative stress and endothelial nitric oxide synthase. Journal of Ethnopharmacology. 134(1). 176–182. 33 indexed citations
19.
Kuang, Dingwei, Huaizhou You, Feng Ding, et al.. (2009). Intima-Media Thickness of the Carotid Artery and Its Correlation Factors in Maintenance Hemodialysis Patients: A Cross-Sectional Study. Blood Purification. 28(3). 181–186. 12 indexed citations
20.
Xue, Jun, et al.. (2007). Effects of HELP Therapy on Acute Ischemic Stroke and Vascular Endothelial Cell Function. Therapeutic Apheresis and Dialysis. 11(3). 171–176. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026